tiprankstipranks
Trending News
More News >
Standard Biotools Inc (LAB)
NASDAQ:LAB
US Market

Standard BioTools (LAB) Financial Statements

Compare
470 Followers

Standard BioTools Financial Overview

Standard BioTools's market cap is currently $442.25M. The company's EPS TTM is $0.04; its P/E ratio is -3.40; Standard BioTools is scheduled to report earnings on February 24, 2026, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 85.33M$ 174.43M$ 106.34M$ 97.95M$ 130.58M
Gross Profit$ 42.54M$ 84.26M$ 50.45M$ 37.05M$ 69.37M
Operating Income$ -110.25M$ -175.24M$ -76.60M$ -116.20M$ -67.46M
EBITDA$ -94.96M$ -118.14M$ -54.46M$ -173.57M$ -44.27M
Net Income$ -74.90M$ -138.88M$ -74.66M$ -190.10M$ -59.24M
Balance Sheet
Cash & Short-Term Investments$ 187.57M$ 292.87M$ 114.89M$ 165.78M$ 28.45M
Total Assets$ 567.75M$ 612.34M$ 323.07M$ 390.31M$ 275.21M
Total Debt$ 30.83M$ 33.00M$ 98.21M$ 102.66M$ 111.65M
Net Debt$ -87.39M$ -133.73M$ 46.51M$ 21.35M$ 83.20M
Total Liabilities$ 143.46M$ 140.62M$ 471.12M$ 471.78M$ 180.62M
Stockholders' Equity$ 424.29M$ 471.72M$ -148.05M$ -81.47M$ 94.60M
Cash Flow
Free Cash Flow$ -82.65M$ -151.81M$ -46.12M$ -93.19M$ -57.33M
Operating Cash Flow$ -74.35M$ -143.45M$ -43.29M$ -89.37M$ -44.06M
Investing Cash Flow$ 24.77M$ 363.17M$ 20.24M$ -88.13M$ -11.95M
Financing Cash Flow$ 570.00K$ -102.62M$ -6.81M$ 230.76M$ 15.96M
Currency in USD

Standard BioTools Earnings and Revenue History

Standard BioTools Debt to Assets

Standard BioTools Cash Flow

Standard BioTools Forecast EPS vs Actual EPS